Randomized study of orally administered fluorinated pyrimidines (capecitabine versus S-1) in women with metastatic or recurrent breast cancer: Japan Breast Cancer Research Network 05 Trial
Title:
Randomized study of orally administered fluorinated pyrimidines (capecitabine versus S-1) in women with metastatic or recurrent breast cancer: Japan Breast Cancer Research Network 05 Trial
Author:
Yamamoto, D. Iwase, S. Tsubota, Y. Ariyoshi, K. Kawaguchi, T. Miyaji, T. Sueoka, N. Yamamoto, C. Teramoto, S. Odagiri, H. Kitamura, K. Nagumo, Y. Yamaguchi, T.